Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Endocrinol Invest ; 37(8): 739-744, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24906975

RESUMEN

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is an independent predictor of type 2 diabetes mellitus (T2DM). Insulin resistance and beta-cell dysfunction are involved in the pathogenesis of T2DM. Insulin resistance is associated with NAFLD but little is known about beta-cell dysfunction and NAFLD. AIM: We tested whether NAFLD severity is associated with insulin sensitivity and beta-cell function in morbidly obese women. SUBJECTS AND METHODS: We studied 61 Caucasian women aged 18-60 years without T2DM and with a body mass index ranging from 35.3 to 48.8 kg/m². The insulin sensitivity index (ISI) and the disposition index (DI) from oral glucose tolerance testing were used as measures of insulin sensitivity and beta-cell function, respectively. Fat was measured by dual-energy X-ray absorptiometry. Fatty liver was diagnosed by ultrasonography and ordinally coded as 0 = none, 1 = light, 2 = moderate, 3 = severe. Proportional-odds logistic regression was used to evaluate the association of NAFLD severity with log(e)ISI and log(e)DI with and without correction for total and truncal fat. RESULTS: The odds of more severe vs. less severe NAFLD decreased for increasing log(e)ISI [odds ratio (OR) 0.40, 95 % CI 0.19-0.84, p < 0.05] and log(e)DI (OR 0.80, 95 % CI 0.69-0.92, p < 0.01). Neither total nor truncal fat had any effect on these associations. CONCLUSION: In morbidly obese women, NAFLD severity is inversely associated with insulin sensitivity and beta-cell function. The association of NAFLD severity with beta-cell dysfunction is stronger than that with insulin resistance.


Asunto(s)
Resistencia a la Insulina , Células Secretoras de Insulina/metabolismo , Insulina/metabolismo , Enfermedad del Hígado Graso no Alcohólico/metabolismo , Obesidad Mórbida/fisiopatología , Grasa Abdominal/diagnóstico por imagen , Absorciometría de Fotón , Adiposidad , Adolescente , Adulto , Índice de Masa Corporal , Femenino , Prueba de Tolerancia a la Glucosa , Humanos , Secreción de Insulina , Italia , Hígado/diagnóstico por imagen , Modelos Logísticos , Persona de Mediana Edad , Enfermedad del Hígado Graso no Alcohólico/diagnóstico por imagen , Enfermedad del Hígado Graso no Alcohólico/etiología , Enfermedad del Hígado Graso no Alcohólico/fisiopatología , Índice de Severidad de la Enfermedad , Ultrasonografía , Adulto Joven
2.
Gynecol Endocrinol ; 28(1): 39-42, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21609196

RESUMEN

Ectopic thyroid tissue in ovarian teratoma or in struma ovarii appears to be histologically identical to the thyroid gland tissue and may virtually exhibit all the pathological patterns found in the thyroid gland. However, the concurrent lymphocytic infiltration of the thyroid gland, as found in Hashimoto's thyroiditis, and of the ectopic thyroid tissue is extremely rare. We describe the case of an 18-years old patient, in which a right ovarian 4 cm cyst has been found during pelvic ultrasound exam. The cyst was resected and microscopic examination of the mass revealed a mature cystic teratoma in which epidermal-like lining with skin adnexa, admixed with respiratory type epithelium, and areas of mature fatty, chondroid and dentigerous tissues were found. In a peripheral area of 0.7 cm  × â€Š0.5 cm, a prominent lymphocytic infiltrate surrounding thyroid follicles was identifiable. Thyroid function evaluation at different time points after surgery, revealed the development of mild hypothyroidism. Anti-TPO and anti-Tg autoantibodies were elevated, at fine needle aspiration biopsy a lymphocytic infiltrate, compatible with Hashimoto's thyroiditis, was present. We report here a rare case of Hashimoto's thyroiditis occurring both in the thyroid and in the ectopic thyroid tissue in the context of a benign cystic teratoma of the ovary.


Asunto(s)
Enfermedad de Hashimoto/complicaciones , Neoplasias Ováricas/diagnóstico , Teratoma/diagnóstico , Adolescente , Biopsia con Aguja Fina , Femenino , Enfermedad de Hashimoto/diagnóstico , Humanos , Quistes Ováricos/complicaciones , Quistes Ováricos/diagnóstico , Quistes Ováricos/patología , Neoplasias Ováricas/complicaciones , Neoplasias Ováricas/patología , Teratoma/complicaciones , Teratoma/patología , Pruebas de Función de la Tiroides
3.
Eur J Appl Physiol ; 112(12): 4027-33, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22457012

RESUMEN

We investigated the relationship between mechanical and energy cost of transport and body mass in running humans. Ten severely obese (body mass ranging from 108.5 to 172.0 kg) and 15 normal-weighted (52.0-89.0 kg) boys and men, aged 16.0-45.8 years, participated in this study. The rate of O(2) consumption was measured and the subjects were filmed with four cameras for kinematic analysis, while running on a treadmill at 8 km h(-1). Mass specific energy cost (C (r)) and external mechanical work (W (ext)) per unit distance were calculated and expressed in joules per kilogram per meter, efficiency (η) was then calculated as W (ext) × C (r) (-1)  × 100. Both mass-specific C (r) and W (ext) were found to be independent of body mass (M) (C (r) = 0.002 M + 3.729, n = 25, R (2) = 0.05; W (ext) = -0.001 M + 1.963, n = 25, R (2) = 0.01). It necessarily follows that the efficiency is also independent of M (η = -0.062 M + 53.3298, n = 25, R (2) = 0.05). The results strongly suggest that the elastic tissues of obese subjects can adapt (e.g., thickening) to the increased mass of the body thus maintaining their ability to store elastic energy, at least at 8 km h(-1) speed, at the same level as the normal-weighted subjects.


Asunto(s)
Peso Corporal/fisiología , Metabolismo Energético , Carrera/fisiología , Adaptación Fisiológica , Adolescente , Adulto , Fenómenos Biomecánicos , Estudios de Casos y Controles , Tejido Elástico/fisiología , Prueba de Esfuerzo , Humanos , Masculino , Obesidad , Consumo de Oxígeno
4.
PLoS One ; 13(10): e0205293, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30339686

RESUMEN

BACKGROUND: Regulating thermogenesis is a major task of thyroid hormones (THs), and involves TH-responsive energetic processes at the central and peripheral level. In severe obesity, little is known on the relationship between THs and resting energy expenditure (REE) before and after weight loss. METHODS: We enrolled 100 euthyroid subjects with severe obesity who were equally distributed between genders. Each was examined before and after completion of a 4-wk inpatient multidisciplinary dieting program and subjected to measurement of thyroid function, REE, fat-free mass (FFM, kg) and percent fat mass (FM). RESULTS: Baseline REE was lower than predicted in 70 obese patients, and overall associated with BMI, FFM and FM but not thyroid-related parameters. By the study end, both BMI and REE decreased (5.5% and 4.1%, p<0.001 vs. baseline) and their percent changes were significantly associated (p<0.05), while no association related percent changes of REE and FFM or FM. Individually, REE decreased in 66 and increased in 34 patients irrespective of gender, BMI and body composition. Weight loss significantly impacted TSH (-6.3%), FT3 (-3.3%) and FT4 levels (3.9%; p<0.001 for all). By the study end, a significant correlation became evident between REE and FT4 (r = 0.42, p<0.001) as well as FT3 (r = 0.24, p<0.05). In stepwise multivariable regression analysis, however, neither THs nor body composition entered the regression equation for REE response to weight loss. CONCLUSIONS: In severe obesity, short-term weight loss discloses a positive relationship between REE and THs.


Asunto(s)
Tejido Adiposo/metabolismo , Metabolismo Energético/fisiología , Obesidad Mórbida/sangre , Tirotropina/sangre , Tiroxina/sangre , Triyodotironina/sangre , Tejido Adiposo/fisiopatología , Adulto , Índice de Masa Corporal , Dieta Reductora , Femenino , Humanos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Obesidad Mórbida/dietoterapia , Obesidad Mórbida/fisiopatología , Descanso/fisiología , Termogénesis/fisiología , Pérdida de Peso
5.
J Clin Endocrinol Metab ; 95(1): 201-8, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19906789

RESUMEN

CONTEXT: Radioactive iodine (RAI) is a common therapy for hyperthyroidism due to Graves' disease. A small but significant proportion of patients have recurrence of hyperthyroidism after RAI therapy. Lithium might increase RAI effectiveness by increasing RAI retention in the thyroid. However, whether lithium favorably affects the long-term outcome of RAI therapy is still a matter of argument. OBJECTIVE: The objective of the study was to compare the efficacy of RAI given with or without concomitant lithium treatment. DESIGN: This was a retrospective cohort study. SETTING: The study was conducted at a tertiary university center. PATIENTS: Six hundred fifty-one patients with newly diagnosed Graves' disease participated in the study. INTERVENTION: Two hundred ninety-eight patients were treated with RAI plus lithium (900 mg/d for 12 d) and 353 with RAI alone. MAIN OUTCOME MEASURES: Proportion of cured patients and time to achieve cure of hyperthyroidism during 1 yr of follow-up was measured. RESULTS: PATIENTS treated with RAI plus lithium had a higher cure rate (91.0%) than those treated with RAI alone (85.0%, P = 0.030). In addition, patients treated with RAI plus lithium were cured more rapidly (median 60 d) than those treated with RAI alone (median 90 d, P = 0.000). Treatment with lithium prevented the serum free T(4) increase after methimazole withdrawal and RAI therapy. Side effects after RAI therapy occurred in a subset of patients and were mild, transient, and without differences in the two groups. CONCLUSIONS: RAI combined with lithium is safe and more effective than RAI alone in the cure of hyperthyroidism due to Graves' disease.


Asunto(s)
Enfermedad de Graves/tratamiento farmacológico , Enfermedad de Graves/radioterapia , Hipertiroidismo/epidemiología , Radioisótopos de Yodo/uso terapéutico , Litio/uso terapéutico , Tiroxina/sangre , Adolescente , Adulto , Anciano , Antitiroideos/uso terapéutico , Estudios de Cohortes , Femenino , Enfermedad de Graves/sangre , Enfermedad de Graves/epidemiología , Humanos , Hipertiroidismo/sangre , Hipertiroidismo/tratamiento farmacológico , Hipertiroidismo/radioterapia , Incidencia , Masculino , Persona de Mediana Edad , Recurrencia , Inducción de Remisión , Estudios Retrospectivos , Factores de Tiempo , Resultado del Tratamiento , Privación de Tratamiento , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA